Results 221 to 230 of about 31,601 (273)

The Switch from Reference Biologic Medicines to Biosimilars in France: The Perspective of Patients and Prescribers on Barriers and Needs. [PDF]

J Multidiscip Healthc
Gaujoux-Viala C, Tropé S, Buisson A, Lacombe F, Bocquet F, Languérand E, Cordurié L, Margulies G, Le Berre C, Vittecoq O.   +9 more
europepmc   +1 more source

Knowledge, Attitudes, and Practices Regarding Biosimilars Among Pharmacists and Physicians in Saudi Arabia: A Scoping Review. [PDF]

Cureus
Alanizi A, Alotaibi R, Babalghaith R, Alzahrani A, Qubaiban R, Hattan A, Alnuhait M, Al Sharif A.   +7 more
europepmc   +1 more source

Single and multiple switches, swap and retransitioning among 28,073 biological drug users with inflammatory bowel diseases: results from the Italian VALORE network. [PDF]

Therap Adv Gastroenterol
Pellegrini G, Spini A, Bellitto C, L'Abbate L, Ingrasciotta Y, Soardo F, Leoni O, Mazzone A, Ancona D, Stella P, Cavazzana A, Scapin A, Lopes S, Belleudi V, Ledda S, Carta P, Rossi P, Ejlli L, Sapigni E, Puccini A, Scarpelli RF, De Sarro G, Tuccori M, Gini R, Allotta A, Addario Pollina S, Da Cas R, Bucaneve G, Mangano AMP, Balducci F, Sorrentino C, Senesi I, Bernardi FF, Trama U, Spila Alegiani S, Mayer F, Massari M, Savarino EV, Variola A, Trifirò G.   +39 more
europepmc   +1 more source

Comparative outcomes of aflibercept biosimilars and reference aflibercept in nAMD: a systematic review and meta-analysis. [PDF]

BMJ Open Ophthalmol
Sawires K, Nithianandan H, Somani S.
europepmc   +1 more source

Follitropin alfa biosimilars: unfounded doubts on the road to reproductive care. [PDF]

Hum Reprod
de Mora F, Howles CM, Trew G.
europepmc   +1 more source

Barriers to adoption of biosimilar insulins in Europe: A mixed-methods study. [PDF]

Diabetes Obes Metab
Car E, Habets G, Vulto AG, Heinemann L, Huys I, Simoens S.   +5 more
europepmc   +1 more source

Halting hyaluronidase hopping to maintain the integrity of Medicare drug price negotiation. [PDF]

J Manag Care Spec Pharm
Kim J, Kesselheim AS, Rome BN.
europepmc   +1 more source

Characterization of a Long-Acting Anti-Human MASP-2 Antibody for the Treatment of Complement-Related Diseases. [PDF]

J Inflamm Res
Han X, Yang C, Wang Z, Fan K, Liu K, Ye H, Zhang W, Zhang J, Hu X, Lin H, Liao C.   +10 more
europepmc   +1 more source

Does the Korean economy depend too much on Samsung? [PDF]

, 2015
Kim, Hyoung Tae
core  

The Expanding Role of Biosimilar in Autoimmune Diseases

Imtiyaz Ahmad, P. Suresh Yadav, Mr. Shailendra Kumar Dwivedi   +2 more
openalex   +1 more source